RR

Ramakrishna Reddy Kaipu

Active Director Director DIN 11255470
DIN 11255470 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramakrishna Reddy Kaipu

Data last updated:

Ramakrishna Reddy Kaipu is a Director at Aurevion Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11255470
Primary Designation Director
Industry Pharma
First Appointment 22 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20252025Active

Board colleagues of Ramakrishna Reddy Kaipu

NameDINCompanyDesignation
Sumathi Butukuri11243904Aurevion Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aurevion Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramakrishna Reddy Kaipu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramakrishna Reddy Kaipu

Ramakrishna Reddy Kaipu currently holds 1 directorship: Aurevion Pharmaceuticals Private Limited (Director, since 22 Aug 2025).

Ramakrishna Reddy Kaipu was first appointed on 22 Aug 2025 as Director at Aurevion Pharmaceuticals Private Limited.

The current boards of Ramakrishna Reddy Kaipu's companies include Sumathi Butukuri (Aurevion Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available